ClinicalTrialsFinder

Adjuvant Immunotherapy Clinical Trials in Guangzhou, Guangdong

1 recruitingGuangzhou, Guangdong, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)

MRDNSCLC (Non-small Cell Lung Cancer)II-IIIB Stages+1 more
Guangdong Association of Clinical Trials115 enrolled2 locationsNCT07120698